KCM
ELV icon

Kingdon Capital Management’s Elevance Health ELV Stock Holding History

Kingdon Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-31,050
Closed -$11.5M – 78
2024
Q4 		$11.5M Buy
+31,050
New +$13M 1.63% 30
2022
Q4 		– Sell
-41,012
Closed -$18.6M – 62
2022
Q3 		$18.6M Buy
+41,012
New +$19.6M 2.38% 7
2018
Q1 		– Sell
-81,619
Closed -$18.4M – 115
2017
Q4 		$18.4M Buy
+81,619
New +$17.4M 1.18% 25

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Kingdon Capital Management's ELV Position: Q1 2025 in Review

Kingdon Capital Management sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 31,050 shares — an estimated $11.5M sold.

Kingdon Capital Management first reported a position in ELV in Q4 2017 and held it in 3 quarters. The position peaked at $18.6M in Q3 2022. 1,665 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Kingdon Capital Management reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Kingdon Capital Management sold 31,050 Elevance Health shares in Q1 2025, an estimated $11.5M.
  • Kingdon Capital Management first reported a position in Elevance Health in Q4 2017 and held it in 3 quarters.
  • Kingdon Capital Management's Elevance Health position peaked at $18.6M in Q3 2022.
  • 1,665 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Kingdon Capital Management's 13F filing for Q1 2025, filed 15 May 2025.